Helium
Medical Gases
Sold as HELIOX 70/30
- Drug class
- Medical Gases
- Availability
- Prescription only
- Routes
- Inhalation, Respiratory (Inhalation)
- Markets covered
- 3
- Products on record
- 8
- FDA reports (12 mo)
- 1
Overview
Helium is an active pharmaceutical ingredient in the Medical Gases group (V03AN). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 2 | July 18, 2025 |
| CA Canada | Health Canada | 4 | May 21, 2025 |
| US United States | FDA | 2 | December 2, 2025 |
GBUnited Kingdom· MHRA
2 products
Uses
To prevent atelectasis and to assist oxygen flow into lung alveoli in cases of severe respiratory obstruction. Also for use in respiratory function tests.
How to take
CACanada· Health Canada
4 products
4 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].
Brands in Canada (1)
USUnited States· FDA
2 products
Sources & citations
- [1]MHRA (UK) · PL159290003 · revised July 18, 2025
- [2]Health Canada (DPD) · 00572888 · revised March 22, 2025
- [3]FDA DailyMed · 12440277-7160-4e… · revised December 2, 2025 [PDF]
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.